CDC issues revised treatment guidance for steroid infections
AHA News Now
Mar 7, 2013
The Centers for Disease Control and Prevention this week issued revised guidance for treating patients injected with contaminated steroid medication recalled from the New England Compounding Center last fall. In a notice to clinicians, the agency said it continues to receive new reports of fungal infection in patients receiving the contaminated methylprednisolone acetate, with most recent cases involving localized infections in the spinal area. CDC urged clinicians to remain vigilant for fungal infections, especially in patients with mild symptoms, and to consider magnetic resonance imaging if clinically warranted. The agency also announced a March 13 conference call on the new guidance.